Literature DB >> 1984619

Controlled trial of a home and ambulatory program for asthmatic children.

D M Hughes1, M McLeod, B Garner, R B Goldbloom.   

Abstract

Care of asthmatic children is often episodic and more therapeutic than preventive. A 2-year randomized, controlled trial involving 95 children measured the impact of a comprehensive home and ambulatory program for pediatric asthma management using objective outcome measures. Interventions for the study group during the first year included 3-month clinic visits, education, and home visits by a specially trained research nurse. Control subjects continued to receive regular care from a family physician or pediatrician. Eight-nine subjects (93%) completed the study. Study subjects had less school absenteeism than control subjects (10.7 vs. 16.0 days, P = .04) and showed significantly better small airway function after 1 year. Asthma severity improved in 13 study subjects and worsened in 5. The reverse was true for control subjects. Study subjects exhibited better metered aerosol technique than control subjects (P = .0005). Fewer days were spent in hospital by the study subjects admitted compared with control subjects (3.67 vs 11.2 days, P = .02). After 1 year, more study than control families (72.1% vs 33.1%, P = .006) reported that their asthmatic child took responsibility for the asthma management. The intervention failed to reduce exposure to secondhand smoke or to household pets. There were no significant differences in medical visits, theophylline levels, or records of asthma symptoms. One year after discontinuing the intervention, a marked "washout" effect was observed. Comprehensive ambulatory programs of childhood asthma management can improve objective measures of illness severity but must be sustained.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1984619

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  32 in total

1.  Costs of asthma.

Authors:  P Hansen
Journal:  Pharmacoeconomics       Date:  1992-09       Impact factor: 4.981

2.  Reducing inequalities in access to health care: developing a toolkit through action research.

Authors:  E C Goyder; L Blank; E Ellis; A Furber; J Peters; K Sartain; C Massey
Journal:  Qual Saf Health Care       Date:  2005-10

Review 3.  Psychological interventions for children with asthma.

Authors:  J Yorke; S Fleming; C Shuldham
Journal:  Cochrane Database Syst Rev       Date:  2005-10-19

4.  Parent reported home smoking bans and toddler (18-30 month) smoke exposure: a cross-sectional survey.

Authors:  N Spencer; C Blackburn; S Bonas; C Coe; A Dolan
Journal:  Arch Dis Child       Date:  2005-07       Impact factor: 3.791

Review 5.  Interventions for educating children who are at risk of asthma-related emergency department attendance.

Authors:  Michelle Boyd; Toby J Lasserson; Michael C McKean; Peter G Gibson; Francine M Ducharme; Michelle Haby
Journal:  Cochrane Database Syst Rev       Date:  2009-04-15

Review 6.  Treatment of chronic asthma in children: the changing role of inhaled corticosteroids. Allergy Section, Canadian Paediatric Society.

Authors: 
Journal:  CMAJ       Date:  1991-09-15       Impact factor: 8.262

Review 7.  The cost of asthma: can it be reduced?

Authors:  C M Mellis; J K Peat; A J Woolcock
Journal:  Pharmacoeconomics       Date:  1993-03       Impact factor: 4.981

8.  Health care provider-delivered adherence promotion interventions: a meta-analysis.

Authors:  Yelena P Wu; Ahna L H Pai
Journal:  Pediatrics       Date:  2014-05-05       Impact factor: 7.124

9.  Asthma at the interface: bridging the gap between general practice and a district general hospital.

Authors:  I Charlton; A G Antoniou; J Atkinson; M J Campbell; E Chapman; T Mackintosh; D Schapira
Journal:  Arch Dis Child       Date:  1994-04       Impact factor: 3.791

Review 10.  Cost-consequence analysis of multimodal interventions with environmental components for pediatric asthma in the state of Maryland.

Authors:  Mandeep S Jassal; Gregory B Diette; David W Dowdy
Journal:  J Asthma       Date:  2013-05-09       Impact factor: 2.515

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.